Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-γ and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet

Treatment of NAFLD with diet, physical activity and exercise

(2017) Manuel Romero-Gómez et al.   JOURNAL OF HEPATOLOGY

Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance

(2017) Ruth C. R. Meex et al.   Nature Reviews Endocrinology

Targeting nuclear receptors for the treatment of fatty liver disease

(2017) Naoki Tanaka et al.   PHARMACOLOGY & THERAPEUTICS

Nonalcoholic fatty liver disease: Evolving paradigms

(2017) Amedeo Lonardo et al.   WORLD JOURNAL OF GASTROENTEROLOGY

The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans

(2016) Stefano Ballestri et al.   ADVANCES IN THERAPY

Hepatic ATF6 Increases Fatty Acid Oxidation to Attenuate Hepatic Steatosis in Mice Through Peroxisome Proliferator–Activated Receptor α

(2016) Xuqing Chen et al.   DIABETES

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

(2016) Giovanni Targher et al.   JOURNAL OF HEPATOLOGY

PPARs and Mitochondrial Metabolism: From NAFLD to HCC

(2016) Tommaso Mello et al.   PPAR Research

Dietary component isorhamnetin is a PPARγ antagonist and ameliorates metabolic disorders induced by diet or leptin deficiency

(2016) Yu Zhang et al.   Scientific Reports

Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome

(2015) Amedeo Lonardo et al.   DIGESTIVE AND LIVER DISEASE

Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease

(2015) Jun Luo et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR

(2015) CHUANZHENG SUN et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Type 2 diabetes mellitus

(2015) Ralph A. DeFronzo et al.   Nature Reviews Disease Primers

Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis

(2015) Robert Schierwagen et al.   Scientific Reports

Intracellular role of exchangeable apolipoproteins in energy homeostasis, obesity and non-alcoholic fatty liver disease

(2014) Chen-Lu Wu et al.   BIOLOGICAL REVIEWS

Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats

(2013) Melissa A. Linden et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Prevalence of nonalcoholic fatty liver disease in mainland of China: A meta-analysis of published studies

(2013) ZhanZhan Li et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance

(2011) Hao Zheng et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Obesity, insulin resistance and free fatty acids

(2011) Guenther Boden   Current Opinion in Endocrinology Diabetes and Obesity

Beneficial effects of exercise training (treadmill) on insulin resistance and nonalcoholic fatty liver disease in high-fat fed C57BL/6 mice

(2010) C.M.M. Marques et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet

(2010) Vanessa Souza-Mello et al.   CLINICAL SCIENCE

Up-regulation of PPARγ in myocardial infarction

(2008) Daniela Fliegner et al.   EUROPEAN JOURNAL OF HEART FAILURE